Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Salesforce is trading near multi-month lows despite healthy margins, strong free cash flow, and a clear path to AI-led product monetization. Use a defined-entry trade to capture a rebound as Agentforce 360 and broader generative AI adoption begin to show through in revenue and ARR acceleration.
Minutes from the central bank's January 28 meeting show the board left the Selic rate at 15% and said it will determine the magnitude and duration of any easing cycle based on evolving economic data. Policymakers stressed maintaining restrictive policy until disinflation is consolidated and inflation expectations align with targets, while noting th…
Rosenblatt has reaffirmed a Buy rating and a $550 price objective for Fabrinet following the company's fiscal 2026 second-quarter results and guidance for the third quarter. Fabrinet reported $1.13 billion in Q2 revenue and non-GAAP EPS of $3.36, and provided Q3 revenue and EPS guidance that implies continued growth. Strength in the Telecom segment…
Raymond James' technical assessment of Newmont Corporation (NEM) identifies negative momentum, weakening relative strength versus the S&P 500, and early selling-pressure volume patterns that may herald a short-term corrective phase. The firm outlines potential support tests at the 50-day moving average near $103.65 and at $97.99, with a weekly brea…
H.C. Wainwright has reiterated a Buy rating on Wave Life Sciences (WVE) and set a $30.00 price target after the company recovered global rights to its RNA editing candidate WVE-006 from GlaxoSmithKline. The research firm points to a clearer regulatory path for alpha-1 antitrypsin deficiency (AATD) accelerated approval and notes additional analyst s…
Acadia Pharmaceuticals received a negative trend vote from the European Medicines Agency’s CHMP on its marketing application for trofinetide in Rett syndrome, prompting a likely move to a formal re-examination that could delay European approval by at least four to six months. Despite the regulatory hurdle, several analysts have reiterated Buy or Ma…
Amazon Web Services says lengthy waits to connect to Europe’s transmission networks are emerging as a principal constraint on its data center expansion plans. Company executives and industry groups are pressing EU policymakers to accelerate grid upgrades and streamline permitting as connection queues of up to seven years – compared with roughly two…
Village Farms (VFF) has been quietly shifting its earnings mix from produce toward higher-margin cannabis exports and energy operations. With a market cap near $377M, positive free cash flow last year, and an EU-GMP export win announced 01/26/2026, the risk/reward favors a tactical long over the next 45 trading days. Entry $3.27, target $4.20, stop…
Ladenburg Thalmann reduced its 12-month price target on OGE Energy to $42.50 from $43.50 and retained a Neutral rating after updating forecasts to reflect close to $800 million in additional transmission and generation project spending. The firm also acknowledged an expected accretion from a proposed battery storage project, which it did not includ…
Sable Offshore Corp. (NYSE: SBLE) saw its stock fall roughly 13% Tuesday morning after the company disclosed an "at the market" program allowing up to $250 million of common stock to be sold through designated agents. The company entered a Sales Agreement with TD Securities and Jefferies, and said the offering will proceed under an effective shelf …
TransMedics' organ care platform is set to benefit from an expanding international footprint after reports of an Italian NOP program. With a $4.58B market cap, positive free cash flow ($120.6M last reported), and heavy short interest that could amplify moves, this is a tactical long for patient traders who accept valuation risk. Entry $134.03, stop…
Massimo Group (NASDAQ:MAMO) saw its stock fall more than 50% after the company disclosed it had signed a non-binding letter of intent to acquire FST Development Company Limited. The deal - proposed to be between $27 million and $35 million - would see Massimo take 100% of FST under a pre-money equity valuation range of about $38 million to $50 mill…
Credo Technology (CRDO) has been punished since its December peak despite accelerating revenue and improving margins. The combination of strong free cash flow, an attractive enterprise-value backdrop and an oversold technical picture argues for a tactical long. This trade idea lays out an entry at $122.00, a stop at $110.00, and a $170.00 target ov…
Palladyne AI Corp. (NASDAQ: PDYN) saw its stock climb about 15% Tuesday morning after announcing a contract with a major U.S. defense prime to provide a propulsion subsystem for an existing U.S. missile system program. The Salt Lake City-based company expects the work to generate nearly $1 million in revenue in 2026, with deliverables due by the en…
BofA Securities moved Popular, Inc. (NASDAQ: BPOP) from Neutral to Buy and increased its price target to $156 from $141, citing expected sustainable mid-teens return on tangible common equity and improving credit trends. The broker also boosted its 2026 EPS estimate and highlighted stronger-than-anticipated Q4 2025 net interest margin as a key driv…
BofA Securities downgraded Figure Technology (FIGR) from Neutral to Underperform and trimmed its price objective to $42 from $43, citing valuation concerns after the stock’s post-IPO rally. FIGR currently trades at $52.31 and shows varied analyst sentiment, with several firms raising targets while BofA highlights an unusually high projected multipl…
BofA Securities has begun coverage of Akoustis Technologies (NASDAQ:AKTS), assigning a Buy rating and a $34.00 price target - a notable premium to the stock's recent trade around $21.98 and a market capitalization near $1.15 billion. The bank's analyst flagged the company's radiopharmaceutical platform, biologically de-risked targets, external part…
BofA Securities upgraded Equity LifeStyle Properties (ELS) from Neutral to Buy and raised its price target to $76 from $74 after the company reported fourth-quarter results. The firm pointed to stable Manufactured Home and Annual Recreational Vehicle revenue as primary growth drivers, while flagging continued market concern about the Seasonal and T…
BofA Securities moved Sigma Lithium Corp. (SGML) from Underperform to Neutral with a $14.00 price target after the company said it had resumed mining. The broker said the restart materially lowers the chance of further timeline delays for producing sellable volumes, but it still warns of liquidity pressure during an estimated three-month ramp and o…
BofA Securities raised its rating on Oshkosh Corporation from Underperform to Neutral and set a $149.00 price target, roughly in line with the stock's recent trading level. The upgrade reflects a view that the company’s portfolio is shifting toward steadier profit sources, lower valuation risk and the Access segment being at a trough, even as Oshko…
Attorneys for 22-year-old Tyler Robinson will ask a Utah judge to disqualify the prosecution in the fatal shooting of conservative activist Charlie Kirk, citing an alleged conflict of interest after the lead prosecutor's 18-year-old daughter witnessed the killing. Prosecutors deny bias and want to display video of the shooting at a televised hearin…
Barclays has flagged Ashtead Group PLC as a top pick for 2026, pointing to an improving end-market outlook, potential for meaningful margin expansion as local volumes recover and efficiency programs scale, and a valuation setup that historically rewards investors buying into troughs in returns. The bank expects upward ROIC momentum in 2026 while th…
DA Davidson has reiterated a Buy rating and a $110 price target on O’Reilly Automotive (ORLY) ahead of the company’s fourth-quarter 2025 earnings release, a view that tracks with the wider analyst consensus. Consensus estimates call for roughly 5% comparable store sales growth for the period and the research firm expects margin improvement, though …
Kepler Cheuvreux upgraded Recordati to 'buy' from 'hold', lifted its price target to €57.50 and cited an improved near-term outlook and attractive valuation after recent moves in the peer group. The brokerage left 2025 forecasts largely intact, trimmed 2026 earnings to account for additional Isturisa-related spending, and expects the company to rep…
Russian steelmaker Severstal reported a sharp fall in 2025 profitability and revenue and warned that steel demand is likely to decline again in 2026 even as it plans to lift production. The company cited lingering economic cooling and reduced construction activity as drivers of lower domestic consumption.
